Matrix metalloproteinase 1: Role in sarcoma biology

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Jawad, Muhammad Umar ^a   Garamszegi, Nandor ^a   Garamszegi, Susanna P ^a   Correa Medina, Mayrin ^b   Diez, Juan A ^b   Wen, Rong ^b   Scully, Sean P ^a  

^a UNIVERSITY OF MIAMI HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA; CHONDROSARCOMA; CONTROLLED STUDY; DEATH; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LASER CAPTURE MICRODISSECTION; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; RNA ANALYSIS; SARCOMA; SARCOMA CELL; STROMA CELL; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BIOLOGICAL MODEL; CANCER INVASION; CANCER TRANSPLANTATION; CELL PROLIFERATION; DISEASE COURSE; ENZYMOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY);

ANIMALIA; MUS;

ANIMALS; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MATRIX METALLOPROTEINASE 1; MICE; MICE, SCID; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SARCOMA;

EID: 78650162101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014250     Document Type: Article

References (48)

1. Basset P, Okada A, Chenard MP, Kannan R, Stoll I, et al. (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol 15: 535-541.
2. Drummond AH, Beckett P, Brown PD, Bone EA, Davidson AH, et al. (1999) Preclinical and clinical studies of MMP inhibitors in cancer. Ann N Y Acad Sci 878: 228-235.
3. Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
4. Eck SM, Hoopes PJ, Petrella BL, Coon CI, Brinckerhoff CE (2008) Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res Treat.
5. Martin MD, Matrisian LM (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724.
6. Witz IP (2008) Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100: 203-229.
7. Polyak K, Haviv I, Campbell IG (2008) Co-evolution of tumor cells and their microenvironment. Trends Genet.
8. Haupt LM, Thompson EW, Trezise AE, Irving RE, Irving MG, et al. (2006) In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts. BMC Cancer 6: 18.
9. Noel A, Jost M, Maquoi E (2008) Matrix metalloproteinases at cancer tumorhost interface. Semin Cell Dev Biol 19: 52-60.
10. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, et al. (2007) Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446: 765-770.
11. Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8: 341-352.
12. Berend KR, Toth AP, Harrelson JM, Layfield LJ, Hey LA, et al. (1998) Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am 80: 11-17.
13. Yuan J, Dutton CM, Scully SP (2005) RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 23: 1467-1474.
14. Luu HH, Kang Q, Park JK, Si W, Luo Q, et al. (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22: 319-329.
15. Fong YC, Dutton CM, Cha SS, Garamszegi N, Sim FH, et al. (2004) Absence of a correlation between the presence of a single nucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma. Clin Cancer Res 10: 7329-7334.
16. Jiang X, Dutton CM, Qi W, Block JA, Brodt P, et al. (2003) Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma. J Orthop Res 21: 1063-1070.
17. Scully SP, Berend KR, Toth A, Qi WN, Qi Z, et al. (2000) Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma Clin Orthop Relat Res. pp 291-303.
18. Scully SP, Amin AR (2000) Gene therapy for chondrocytes. Clin Orthop Relat Res. pp S220-221.
19. van Hinsbergh VW, Engelse MA, Quax PH (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26: 716- 728.
20. Erickson HS, Albert PS, Gillespie JW, Wallis BS, Rodriguez-Canales J, et al. (2007) Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samples. Lab Invest 87: 951-962.
21. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, et al. (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704.
22. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32.
23. Bhuvarahamurthy V, Kristiansen GO, Johannsen M, Loening SA, Schnorr D, et al. (2006) In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Oncol Rep 15: 1379-1384.
24. Salmela MT, Karjalainen-Lindsberg ML, Puolakkainen P, Saarialho-Kere U (2001) Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma. Br J Cancer 85: 383-392.
25. MacDougall JR, Matrisian LM (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362.
26. Healey JH, Hoang BH (2008) Editorial comment: cancer biology-lessons learned from sarcoma. Clin Orthop Relat Res 466: 2029-2030.
27. Makino H, Uetake H, Danenberg K, Danenberg PV, Sugihara K (2008) Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer. BMC Cancer 8: 210.
28. Sooriakumaran P, Henderson A, Denham P, Langley SE (2008) A Novel Method of Obtaining Prostate Tissue for Gene Expression Profiling. Int J Surg Pathol.
29. Zheng MH, Xu J, Robbins P, Pavlos N, Wysocki S, et al. (2000) Gene expression of vascular endothelial growth factor in giant cell tumors of bone. Hum Pathol 31: 804-812.
30. Blackburn JS, Rhodes CH, Coon CI, Brinckerhoff CE (2007) RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res 67: 10849-10858.
31. McCawley LJ, Crawford HC, King LE, Jr., Mudgett J, Matrisian LM (2004) A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res 64: 6965-6972.
32. Witty JP, Lempka T, Coffey RJ, Jr., Matrisian LM (1995) Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 55: 1401-1406.
33. Kerkela E, Ala-aho R, Klemi P, Grenman S, Shapiro SD, et al. (2002) Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 198: 258-269.
34. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, et al. (2003) Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35: 252-257.
35. Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, et al. (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A 104: 6740-6745.
36. Sauter W, Rosenberger A, Beckmann L, Kropp S, Mittelstrass K, et al. (2008) Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev 17: 1127-1135.
37. Rio MC (2005) From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. Biochimie 87: 299-306.
38. Merchan JR, Tang J, Hu G, Lin Y, Mutter W, et al. (2006) Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. J Natl Cancer Inst 98: 756-764.
39. Wyatt CA, Geoghegan JC, Brinckerhoff CE (2005) Short hairpin RNAmediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res 65: 11101-11108.
40. Rundhaug JE (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-285.
41. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, et al. (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277: 36288-36295.
42. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271: 10079-10086.
43. Goerge T, Barg A, Schnaeker EM, Poppelmann B, Shpacovitch V, et al. (2006) Tumor-derived matrix metalloproteinase-1 targets endothelial proteinaseactivated receptor 1 promoting endothelial cell activation. Cancer Res 66: 7766-7774.
44. Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J (2000) Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486: 247-251.
45. Apelqvist A, Ahlgren U, Edlund H (1997) Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr Biol 7: 801-804.
46. Garamszegi N, Garamszegi S, Scully PS (2008) Matrix Metalloproteinase- 1Cellular distribution role in Osteosarcoma cell Invasiveness. Exp Cell Res Under Review.
47. Li Y, Song Y, Zhao L, Gaidosh G, Laties AM, et al. (2008) Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat Protoc 3: 1703-1708.
48. Thrall DE, Rosner GL, Azuma C, McEntee MC, Raleigh JA (1997) Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning. Radiother Oncol 44: 171-176.